Aster DM Healthcare Limited (NSE:ASTERDM)
India
· Delayed Price · Currency is INR 635.10
-18.15 (-2.78%)
At close: Dec 5, 2025
Aster DM Healthcare Revenue
Aster DM Healthcare had revenue of 11.97B INR in the quarter ending September 30, 2025, with 10.20% growth. This brings the company's revenue in the last twelve months to 43.25B, up 7.68% year-over-year. In the fiscal year ending March 31, 2025, Aster DM Healthcare had annual revenue of 41.38B with 11.88% growth.
Revenue (ttm)
43.25B
Revenue Growth
+7.68%
P/S Ratio
7.59
Revenue / Employee
2.82M
Employees
15,334
Market Cap
328.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 41.38B | 4.40B | 11.88% |
| Mar 31, 2024 | 36.99B | 7.05B | 23.54% |
| Mar 31, 2023 | 29.94B | -72.59B | -70.80% |
| Mar 31, 2022 | 102.53B | 16.45B | 19.11% |
| Mar 31, 2021 | 86.08B | -434.50M | -0.50% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Mankind Pharma | 135.46B |
| Aurobindo Pharma | 325.14B |
| Alkem Laboratories | 138.90B |
Aster DM Healthcare News
- 18 days ago - Aster DM Healthcare Ltd (BOM:540975) Q2 2026 Earnings Call Highlights: Robust Growth and ... - GuruFocus
- 18 days ago - Q2 2026 Aster DM Healthcare Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Stocks hitting 52-week highs today: Aster DM Healthcare, Ather Energy, and RBL Bank among top movers - Business Upturn
- 2 months ago - Aster DM Healthcare CEO of Digital Health Dr. Harsha Rajaram resigns - Business Upturn
- 3 months ago - Aster DM Healthcare share price: HSBC maintains buy, sees 6% upside as merger with QCIL progresses - Business Upturn
- 4 months ago - Aster DM Healthcare acquires additional 13% stake in DRCM for Rs 63.01 crore, raises holding to 70.49% - Business Upturn
- 6 months ago - Aster DM Healthcare lines up Rs 1,900 crore capex to expand presence - The Times of India
- 7 months ago - Aster DM Healthcare shares drop over 3% following Q4 FY25 Results - Business Upturn